Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IDYA

IDEAYA Biosciences (IDYA)

IDEAYA Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IDYA
DateTimeSourceHeadlineSymbolCompany
08/10/20216:00AMPR Newswire (US)IDEAYA Biosciences, Inc. Reports Second Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:IDYAIDEAYA Biosciences Inc
08/02/20216:00AMPR Newswire (US)IDEAYA Biosciences to Participate in Panel Discussion at 2021 Wedbush PacGrow Healthcare Virtual Conference on August 10, 2021NASDAQ:IDYAIDEAYA Biosciences Inc
07/29/20215:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDYAIDEAYA Biosciences Inc
07/29/20215:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDYAIDEAYA Biosciences Inc
07/12/20214:11PMPR Newswire (US)IDEAYA Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional ...NASDAQ:IDYAIDEAYA Biosciences Inc
07/12/20214:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDYAIDEAYA Biosciences Inc
07/08/20217:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDYAIDEAYA Biosciences Inc
07/08/20217:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDYAIDEAYA Biosciences Inc
07/08/20214:03PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:IDYAIDEAYA Biosciences Inc
07/08/20215:39AMTipRanksIDEAYA Prices 4.6M Common Stock Offering; Street Says BuyNASDAQ:IDYAIDEAYA Biosciences Inc
07/07/20219:29PMPR Newswire (US)IDEAYA Announces Pricing of Public Offering of Common StockNASDAQ:IDYAIDEAYA Biosciences Inc
07/06/20214:04PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:IDYAIDEAYA Biosciences Inc
07/06/20214:01PMPR Newswire (US)IDEAYA Announces Proposed Public Offering of Common StockNASDAQ:IDYAIDEAYA Biosciences Inc
06/28/20216:07AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDYAIDEAYA Biosciences Inc
06/28/20216:00AMPR Newswire (US)IDEAYA Announces IDE397 Phase 1 Clinical Pharmacodynamic Data and Phase 2 Initiation of Darovasertib and Crizotinib Combinati...NASDAQ:IDYAIDEAYA Biosciences Inc
06/16/20216:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDYAIDEAYA Biosciences Inc
06/16/20215:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDYAIDEAYA Biosciences Inc
06/16/20215:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDYAIDEAYA Biosciences Inc
06/16/20215:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDYAIDEAYA Biosciences Inc
06/16/20215:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDYAIDEAYA Biosciences Inc
06/14/20214:00PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDYAIDEAYA Biosciences Inc
05/24/20216:01AMPR Newswire (US)IDEAYA Biosciences to Present at 2021 Jefferies Virtual Healthcare ConferenceNASDAQ:IDYAIDEAYA Biosciences Inc
05/10/20214:02PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IDYAIDEAYA Biosciences Inc
05/10/20216:05AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDYAIDEAYA Biosciences Inc
05/10/20216:00AMPR Newswire (US)IDEAYA Biosciences, Inc. Reports First Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:IDYAIDEAYA Biosciences Inc
05/10/20216:00AMPR Newswire (US)IDEAYA Announces Dose Expansion in Phase 1/2 Study of Darovasertib and Crizotinib Combination based on Early Clinical Efficac...NASDAQ:IDYAIDEAYA Biosciences Inc
05/06/20216:00AMPR Newswire (US)IDEAYA to Participate in Upcoming May 2021 Investor Relations EventNASDAQ:IDYAIDEAYA Biosciences Inc
04/29/20214:29PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IDYAIDEAYA Biosciences Inc
04/19/20216:00AMPR Newswire (US)IDEAYA Biosciences Announces Agenda for Inaugural Synthetic Lethality Investor Day on Tuesday, April 20, 2021NASDAQ:IDYAIDEAYA Biosciences Inc
04/16/20216:00AMPR Newswire (US)IDEAYA Reports Darovasertib (IDE196) Monotherapy Overall Survival Data and Observes Early Partial Responses in Binimetinib Co...NASDAQ:IDYAIDEAYA Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:IDYA